Journal profile · Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
ScienceRise: Pharmaceutical Science
ISSN 2519-4844 · eISSN 2519-4852 · PC Technology Center · Ukraine
ScienceRise: Pharmaceutical Science: fully open access; APC about USD 53; review about 6 weeks (community reports); 59 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
ScienceRise: Pharmaceutical Science is published by PC Technology Center. By OpenAlex counts of its recent articles, its largest topics are Medicinal Plant Research, Analytical Methods in Pharmaceuticals and Medical and Pharmaceutic Studies, together about 37.3% of its articles. Its main subfields are Plant Science. (generated from OpenAlex topic counts and CAS ranking data)
«ScienceRise: Pharmaceutical Science» – scientific peer-reviewed journal, published 6 times a year, included in category «A» «List of scientific professional editions of Ukraine» (Сertificated by order of Ministry of Education and Science of Ukraine No. 420 from 19.04.2021). Registration of an entity in the media sector: Decision of the National Council of Ukraine on Television and Radio Broadcasting No. 695 dated August 10, 2023, protocol No. 17 (media identifier R30-01130). The main mission of the journal – dissemination of the results of scientific research aimed at ensuring the quality of pharmaceutical assistance to the population through targeted search and modern pharmaceutical development of innovative medicines, the creation of modern quality management systems at pharmaceutical enterprises in the industry. In the journal «ScienceRise: Pharmaceutical Science» publishes research designed and implemented taking into account the Quality by design concept with widespread use of computational methods. The journal is intended for scientists, pharmacists, doctors, educators, and healthcare professionals. Innovations in pharmaceutical science - for practical use. ISSN 2519-4844, E-ISSN 2519-4852, ISSN-L 2519-4844Drawing up the items of the publication ethics policy of the journal «ScienceRise: Pharmaceutical Science» Editors followed the recommendations of Committee on Publication Ethics (COPE).
From the journal's Aims & Scope
Research area (LetPub): Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
Editor-in-chief Victoriya GeorgiyantsPublisher website
Editorial board by country: 1 in mainland China (about 4%); most named Ukraine 13, Italy 2, Poland 2, Egypt 2, Mainland China 1 (23 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Medicinal Plant ResearchAgricultural and Biological Sciences12.9%
- Analytical Methods in PharmaceuticalsChemistry12.6%
- Medical and Pharmaceutic StudiesPharmacology, Toxicology and Pharmaceutics11.8%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics5.4%
- Plant chemical constituents analysisAgricultural and Biological Sciences5.3%
- Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance4.6%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics4.4%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| General Pharmacology, Toxicology and Pharmaceutics | Q3 | 48/79 | 39th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.6LetPub ·
- SJR 2026-06
- 0.2LetPub ·
- SNIP 2026-06
- 0.42LetPub ·
- h-index
- 10OpenAlex ·
- i10-index
- 13OpenAlex ·
- 2-year mean citedness
- 0.71OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 564 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 33 | 33 | 107 |
| 2025 | 59 | 59 | 192 |
| 2024 | 64 | 64 | 194 |
| 2023 | 60 | 60 | 213 |
| 2022 | 57 | 57 | 134 |
| 2021 | 58 | 58 | 101 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 6 weeksLetPub ·
- Peer review
- Double blind peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | EUR 50 | — | — | |
| LetPub | EUR 50 | No | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Reference style
- Numbered, in order of citation
- Graphical abstract
- Required
Article types accepted1
- original research articlesoriginal research articles: scientific works should contain deep and high-quality innovative research, be scientifically sound and directed for use in practical…Length not stated
Policy excerpts from the journal's websiteAI use, Conflicts of interest, Publication ethics, License & copyright, Plagiarism
- AI use
AI policy: AI not used for substantive parts; technical AI use must be human-checked and disclosed. Model summary
Artificial intelligence was not used to write any of the substantive parts of the manuscript. Any use of artificial intelligence for technical tasks (e.g., grammar checking, etc.) was additionally checked by a human from among the authors of the manuscript and indicated in the appropriate section of the manuscript text.
Source ↗Publisher website ·- Conflicts of interest
Conflict of interest must be indicated in the manuscript. Model summary
Any conflict of interest is indicated in the text of the manuscript in the appropriate section.
Source ↗Publisher website ·- Publication ethics
Bioethics policy compliance required for all articles. Model summary
All articles must comply with the Bioethics policy.
Source ↗Publisher website ·- License & copyright Copyright Notice
Copyright/License: CC BY 4.0, authors retain authorship, first publication rights to journal. Model summary
The consolidation and conditions for the transfer of copyright (identification of authorship) is carried out in the License Agreement. In particular, the authors reserve the right to the authorship of their manuscript and transfer the first publication of this work to the journal under the terms of the Creative Commons Attribution 4.0 International License. At the same time, they have the right to…
Source ↗Publisher website ·- Plagiarism
Originality: manuscript must be unique and not published previously in any language. Model summary
The material of the manuscript is unique and has not been published previously in whole or in part in the language in which the manuscript is sent to the editorial office of the "ScienceRise: Pharmaceutical Science", as well as in any other language.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- PC Technology Center
- Country or region
- Ukraine
- Language
- English
- ISSN
- 2519-4844
- Electronic ISSN
- 2519-4852
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about ScienceRise: Pharmaceutical Science
How long does peer review take at ScienceRise: Pharmaceutical Science?
Authors report an average review time of about 6 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of ScienceRise: Pharmaceutical Science?
According to the journal's author guidelines: Reference style: Numbered, in order of citation; Graphical abstract: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of ScienceRise: Pharmaceutical Science based?
Of the 23 board members whose country the journal's board page names, 1 (about 4%) are in mainland China; the countries named most often are Ukraine (13), Italy (2) and Poland (2). Counted from the institutions listed on the board page; for reference only.
Which databases index ScienceRise: Pharmaceutical Science?
According to LetPub and DOAJ records, ScienceRise: Pharmaceutical Science is indexed in Scopus.
Is ScienceRise: Pharmaceutical Science open access, and what is the APC?
ScienceRise: Pharmaceutical Science is a fully open-access journal. APC about USD 53.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .